219 related articles for article (PubMed ID: 36139437)
1. CAR-T-Cell Therapy for Solid Tumors Positive for Fibronectin Extra Domain B.
Zhang Z; Liu C; Yang Z; Yin H
Cells; 2022 Sep; 11(18):. PubMed ID: 36139437
[TBL] [Abstract][Full Text] [Related]
2. CAR-T Therapy Targets Extra Domain B of Fibronectin Positive Solid Tumor Cells.
Tang J; Liu N; Zhu Y; Li Y; Zhao X
Immunol Invest; 2023 Nov; 52(8):985-996. PubMed ID: 37815216
[TBL] [Abstract][Full Text] [Related]
3. Treating solid tumors with TCR-based chimeric antigen receptor targeting extra domain B-containing fibronectin.
Zhang Z; Liu C; Wang M; Sun R; Yang Z; Hua Z; Wu Y; Wu M; Wang H; Qiu W; Yin H; Yang M
J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37586774
[TBL] [Abstract][Full Text] [Related]
4. Antitumor Effects of CAR T Cells Redirected to the EDB Splice Variant of Fibronectin.
Wagner J; Wickman E; Shaw TI; Anido AA; Langfitt D; Zhang J; Porter SN; Pruett-Miller SM; Tillman H; Krenciute G; Gottschalk S
Cancer Immunol Res; 2021 Mar; 9(3):279-290. PubMed ID: 33355188
[TBL] [Abstract][Full Text] [Related]
5. Extra-domain B of fibronectin as an alternative target for drug delivery and a cancer diagnostic and prognostic biomarker for malignant glioma.
Saw PE; Xu X; Kang BR; Lee J; Lee YS; Kim C; Kim H; Kang SH; Na YJ; Moon HJ; Kim JH; Park YK; Yoon W; Kim JH; Kwon TH; Choi C; Jon S; Chong K
Theranostics; 2021; 11(2):941-957. PubMed ID: 33391514
[TBL] [Abstract][Full Text] [Related]
6. Impact of VEGF-dependent tumour micro-environment on EDB fibronectin expression by subcutaneous human tumour xenografts in nude mice.
Coltrini D; Ronca R; Belleri M; Zardi L; Indraccolo S; Scarlato V; Giavazzi R; Presta M
J Pathol; 2009 Dec; 219(4):455-62. PubMed ID: 19824060
[TBL] [Abstract][Full Text] [Related]
7. Nanoparticles targeting extra domain B of fibronectin-specific to the atherosclerotic lesion types III, IV, and V-enhance plaque detection and cargo delivery.
Yu M; Ortega CA; Si K; Molinaro R; Schoen FJ; Leitao RFC; Xu X; Mahmoudi M; Ahn S; Liu J; Saw PE; Lee IH; Brayner MMB; Lotfi A; Shi J; Libby P; Jon S; Farokhzad OC
Theranostics; 2018; 8(21):6008-6024. PubMed ID: 30613278
[TBL] [Abstract][Full Text] [Related]
8. Anti-Extra Domain B Splice Variant of Fibronectin Antibody-Drug Conjugate Eliminates Tumors with Enhanced Efficacy When Combined with Checkpoint Blockade.
Hooper AT; Marquette K; Chang CB; Golas J; Jain S; Lam MH; Guffroy M; Leal M; Falahatpisheh H; Mathur D; Chen T; Kelleher K; Khandke K; Muszynska E; Loganzo F; Rosfjord E; Lucas J; Kan Z; Subramanyam C; O'Donnell C; Neri D; Gerber HP; May C; Sapra P
Mol Cancer Ther; 2022 Sep; 21(9):1462-1472. PubMed ID: 35793468
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive assessment and therapeutic monitoring of drug-resistant colorectal cancer by MR molecular imaging of extradomain-B fibronectin.
Vaidya A; Ayat N; Buford M; Wang H; Shankardass A; Zhao Y; Gilmore H; Wang Z; Lu ZR
Theranostics; 2020; 10(24):11127-11143. PubMed ID: 33042274
[TBL] [Abstract][Full Text] [Related]
10. MRI of breast tumor initiating cells using the extra domain-B of fibronectin targeting nanoparticles.
Sun Y; Kim HS; Park J; Li M; Tian L; Choi Y; Choi BI; Jon S; Moon WK
Theranostics; 2014; 4(8):845-57. PubMed ID: 24955145
[TBL] [Abstract][Full Text] [Related]
11. Targeting the extra domain A of fibronectin for cancer therapy with CAR-T cells.
Martín-Otal C; Lasarte-Cia A; Serrano D; Casares N; Conde E; Navarro F; Sánchez-Moreno I; Gorraiz M; Sarrión P; Calvo A; De Andrea CE; Echeveste J; Vilas A; Rodriguez-Madoz JR; San Miguel J; Prosper F; Hervas-Stubbs S; Lasarte JJ; Lozano T
J Immunother Cancer; 2022 Aug; 10(8):. PubMed ID: 35918123
[TBL] [Abstract][Full Text] [Related]
12. T cells expressing NKG2D chimeric antigen receptors efficiently eliminate glioblastoma and cancer stem cells.
Yang D; Sun B; Dai H; Li W; Shi L; Zhang P; Li S; Zhao X
J Immunother Cancer; 2019 Jul; 7(1):171. PubMed ID: 31288857
[TBL] [Abstract][Full Text] [Related]
13. Preclinical Assessment of the Effectiveness of Magnetic Resonance Molecular Imaging of Extradomain-B Fibronectin for Detection and Characterization of Oral Cancer.
Hall RC; Ayat NR; Qiao PL; Vaidya AM; Ma D; Aminoshariae A; Stojanov I; Lu ZR
Mol Imaging Biol; 2020 Dec; 22(6):1532-1542. PubMed ID: 32789648
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance molecular imaging of extradomain B fibronectin enables detection of pancreatic ductal adenocarcinoma metastasis.
Qiao PL; Gargesha M; Liu Y; Laney VEA; Hall RC; Vaidya AM; Gilmore H; Gawelek K; Scott BB; Roy D; Wilson DL; Lu ZR
Magn Reson Imaging; 2022 Feb; 86():37-45. PubMed ID: 34801672
[TBL] [Abstract][Full Text] [Related]
15. Expression of fibronectin isoforms in human breast tissue: production of extra domain A+/extra domain B+ by cancer cells and extra domain A+ by stromal cells.
Matsumoto E; Yoshida T; Kawarada Y; Sakakura T
Jpn J Cancer Res; 1999 Mar; 90(3):320-5. PubMed ID: 10359047
[TBL] [Abstract][Full Text] [Related]
16. A novel human fibronectin cryptic sequence unmasked by the insertion of the angiogenesis-associated extra type III domain B.
Balza E; Sassi F; Ventura E; Parodi A; Fossati S; Blalock W; Carnemolla B; Castellani P; Zardi L; Borsi L
Int J Cancer; 2009 Aug; 125(4):751-8. PubMed ID: 19479996
[TBL] [Abstract][Full Text] [Related]
17. EDB fibronectin and angiogenesis -- a novel mechanistic pathway.
Khan ZA; Chan BM; Uniyal S; Barbin YP; Farhangkhoee H; Chen S; Chakrabarti S
Angiogenesis; 2005; 8(3):183-96. PubMed ID: 16308732
[TBL] [Abstract][Full Text] [Related]
18. TGF-β induces oncofetal fibronectin that, in turn, modulates TGF-β superfamily signaling in endothelial cells.
Ventura E; Weller M; Macnair W; Eschbach K; Beisel C; Cordazzo C; Claassen M; Zardi L; Burghardt I
J Cell Sci; 2018 Jan; 131(1):. PubMed ID: 29158223
[TBL] [Abstract][Full Text] [Related]
19. A serologically assessed neo-epitope biomarker of cellular fibronectin degradation is related to pulmonary fibrosis.
Hansen AH; Breisnes HW; Prior TS; Hilberg O; Rasmussen DGK; Genovese F; Lukassen MV; Svensson B; Langholm LL; Manon-Jensen T; Karsdal MA; Leeming DJ; Bendstrup E; Sand JMB
Clin Biochem; 2023 Aug; 118():110599. PubMed ID: 37343745
[TBL] [Abstract][Full Text] [Related]
20. Mice lacking the EDB segment of fibronectin develop normally but exhibit reduced cell growth and fibronectin matrix assembly in vitro.
Fukuda T; Yoshida N; Kataoka Y; Manabe R; Mizuno-Horikawa Y; Sato M; Kuriyama K; Yasui N; Sekiguchi K
Cancer Res; 2002 Oct; 62(19):5603-10. PubMed ID: 12359774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
